Catalyst Wire Dossier Catalyst Wire Dossier

WATCHMAN Left Atrial Appendage Occlusion Device

· Boston Scientific
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WATCHMAN Left Atrial Appendage Occlusion Device, covering 2015-09-24 to 2015-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban [Phase 4]

See pricing